Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro

G R Upchurch1, J W Ford, S J Weiss

  • 1Jobst Vascular Research Laboratories, Section of Vascular Surgery, Department of Surgery, University of Michigan Medical School, USA. riversu@umich.edu

Abstract

Insights

Diminished nitric oxide (NO) production in vascular smooth muscle cells increases matrix metalloproteinase-9 (MMP-9) expression and activity. This suggests NO plays a role in MMP-9-mediated vessel wall damage.

Area of Science:

  • Vascular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Nitric oxide (NO) is crucial for vascular homeostasis.
  • Matrix metalloproteinases (MMPs) are implicated in vascular remodeling and disease.
  • The relationship between NO bioavailability and MMP expression in vascular smooth muscle cells (SMCs) requires further elucidation.

Purpose of the Study:

  • To investigate the effect of diminished bioavailable nitric oxide (NO) on matrix metalloproteinase (MMP) expression and activation in rat aortic SMCs (RA-SMCs).

Main Methods:

  • RA-SMCs were treated with increasing concentrations of L-N-monomethyl arginine (L-NMMA), a NO synthase inhibitor, and proinflammatory cytokines.
  • Nitrite/nitrate levels, MMP activity (zymography), MMP-9 mRNA, and MMP-9 protein were quantified.

Main Results:

  • L-NMMA treatment dose-dependently decreased nitrite and nitrate production.
  • MMP-9 activity, mRNA, and protein levels significantly increased with L-NMMA exposure.
  • No significant changes were observed in MMP-2 levels.

Conclusions:

  • Inhibition of NO synthesis in RA-SMCs leads to a selective, dose-dependent increase in MMP-9 expression and synthesis.
  • These findings indicate that reduced NO bioavailability may contribute to vascular damage via MMP-9 upregulation.